Suzanne Brissette
About
Suzanne Brissette is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Pharmacology.
According to data from OpenAlex, Suzanne Brissette has authored 57 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Public Health, Environmental and Occupational Health, 36 papers in Epidemiology and 12 papers in Pharmacology. Recurrent topics in Suzanne Brissette's work include Opioid Use Disorder Treatment (42 papers), Substance Abuse Treatment and Outcomes (27 papers) and HIV, Drug Use, Sexual Risk (18 papers). Suzanne Brissette is often cited by papers focused on Opioid Use Disorder Treatment (42 papers), Substance Abuse Treatment and Outcomes (27 papers) and HIV, Drug Use, Sexual Risk (18 papers). Suzanne Brissette collaborates with scholars based in Canada, United Arab Emirates and Iran. Suzanne Brissette's co-authors include David C. Marsh, Eugenia Oviedo‐Joekes, Martin T. Schechter, Daphne Guh, Aslam H. Anis, Bohdan Nosyk, Michael Krausz, Kirsten Marchand, Pierre Lauzon and Julie Bruneau and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and American Journal of Psychiatry.
In The Last Decade
Suzanne Brissette
57 papers receiving 1.6k citations
Peers
Suzanne Brissette
Ambros Uchtenhagen Switzerland
Uwe Verthein Germany
Nick Lintzeris Australia
John A. Renner United States
Genie L. Bailey United States
Helge Waal Norway
Eugenia Oviedo‐Joekes Canada
Kenneth B. Stoller United States
Christian Haasen Germany
Lucy Thi Tran Australia
Citations per year, relative to Suzanne Brissette Suzanne Brissette (= 1×)
peers
Ambros Uchtenhagen
Countries citing papers authored by Suzanne Brissette
Since
Specialization
Citations
This map shows the geographic impact of Suzanne Brissette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Brissette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Brissette more than expected).
Fields of papers citing papers by Suzanne Brissette
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Suzanne Brissette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Brissette. The network helps show where Suzanne Brissette may publish in the future.
Co-authorship network of co-authors of Suzanne Brissette
This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne Brissette. A scholar is included among the top collaborators of Suzanne Brissette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne Brissette. Suzanne Brissette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Socías, M. Eugenia, et al.. (2024). Impact of Depressive Symptom Severity on Buprenorphine/Naloxone and Methadone Outcomes in People With Prescription-Type Opioid Use Disorder: Results From a Pragmatic Randomized Controlled Trial. Journal of Dual Diagnosis. 20(3). 189–200.
2.
Rizkallah, Élie, et al.. (2024). Absence of Evidence for Sustained Effects of Daily Cannabidiol Administration on Anandamide Plasma Concentration in Individuals with Cocaine Use Disorder: Exploratory Findings from a Randomized Controlled Trial. Cannabis and Cannabinoid Research. 10(2). e341–e352.
3.
Sharafi, Heidar, Sarah Drouin, Suzanne Brissette, et al.. (2023). Associations Between Buprenorphine\Naloxone and Methadone Treatment and non-Opioid Substance Use in Prescription-Type Opioid Use Disorder: Secondary Analyses From the OPTIMA Study: Associations entre le traitement avec la buprénorphine/naloxone et avec la méthadone et l'utilisation de substances non opioïdes dans le trouble lié à l'usage d'opioïdes de type sur ordonnance : analyses secondaires de l'étude OPTIMA. The Canadian Journal of Psychiatry. 69(4). 252–263.
4.
Socías, M. Eugenia, et al.. (2022). Effects of Buprenorphine/Naloxone and Methadone on Depressive Symptoms in People with Prescription Opioid Use Disorder: A Pragmatic Randomised Controlled Trial. The Canadian Journal of Psychiatry. 68(8). 572–585.
5.
Socías, M. Eugenia, et al.. (2022). Buprenorphine/naloxone and methadone effectiveness for reducing craving in individuals with prescription opioid use disorder: Exploratory results from an open-label, pragmatic randomized controlled trial. Drug and Alcohol Dependence. 239. 109604–109604.
6.
Jutras‐Aswad, Didier, Bernard Le Foll, Keith Ahamad, et al.. (2022). Flexible Buprenorphine/Naloxone Model of Care for Reducing Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: An Open-Label, Pragmatic, Noninferiority Randomized Controlled Trial. American Journal of Psychiatry. 179(10). 726–739.
7.
Rizkallah, Élie, Paméla Thébault, Stéphanie Lepage, et al.. (2021). Exploring cannabidiol effects on inflammatory markers in individuals with cocaine use disorder: a randomized controlled trial. Neuropsychopharmacology. 46(12). 2101–2111.
8.
Brissette, Suzanne, et al.. (2021). Cannabidiol as a treatment for craving and relapse in individuals with cocaine use disorder: a randomized placebo‐controlled trial. Addiction. 116(9). 2431–2442.
9.
Grande, Claudio Del, Alina Dyachenko, Janusz Kaczorowski, et al.. (2021). Preferences for research design and treatment of comorbid depression among patients with an opioid use disorder: A cross-sectional discrete choice experiment. Drug and Alcohol Dependence. 226. 108857–108857.
10.
Palis, Heather, Daphne Guh, Scott Macdonald, et al.. (2020). Longitudinal patterns of cocaine use among patients receiving injectable hydromorphone or diacetylmorphine for the treatment of opioid use disorder: A growth curve modeling approach. Drug and Alcohol Dependence. 218. 108333–108333.
11.
Oviedo‐Joekes, Eugenia, Heather Palis, Daphne Guh, et al.. (2019). Adverse Events During Treatment Induction With Injectable Diacetylmorphine and Hydromorphone for Opioid Use Disorder. Journal of Addiction Medicine. 13(5). 354–361.
12.
Oviedo‐Joekes, Eugenia, Heather Palis, Daphne Guh, et al.. (2019). Treatment with injectable hydromorphone: Comparing retention in double blind and open label treatment periods. Journal of Substance Abuse Treatment. 101. 50–54.
13.
Brissette, Suzanne, François Lespérance, Paul Lespérance, et al.. (2018). A pilot, open-label, 8-week study evaluating desvenlafaxine for treatment of major depression in methadone-maintained individuals with opioid use disorder. International Clinical Psychopharmacology. 33(5). 268–273.
14.
Palis, Heather, Kirsten Marchand, Daphne Guh, et al.. (2017). Men’s and women’s response to treatment and perceptions of outcomes in a randomized controlled trial of injectable opioid assisted treatment for severe opioid use disorder. Substance Abuse Treatment Prevention and Policy. 12(1). 25–25.
15.
Oviedo‐Joekes, Eugenia, Luis Sordo, Daphne Guh, et al.. (2014). Predictors of non-use of illicit heroin in opioid injection maintenance treatment of long-term heroin dependence. Addictive Behaviors. 41. 81–86.
16.
Oviedo‐Joekes, Eugenia, Daphne Guh, Kirsten Marchand, et al.. (2014). Differential long-term outcomes for voluntary and involuntary transition from injection to oral opioid maintenance treatment. Substance Abuse Treatment Prevention and Policy. 9(1). 23–23.
17.
Oviedo‐Joekes, Eugenia, et al.. (2011). Potency ratio of hydromorphone and diacetylmorphine in substitution treatment for long-term opioid dependency. Journal of Opioid Management. 7(5). 371–376.
18.
Oviedo‐Joekes, Eugenia, Daphne Guh, Suzanne Brissette, et al.. (2010). Double-blind injectable hydromorphone versus diacetylmorphine for the treatment of opioid dependence: A pilot study. Journal of Substance Abuse Treatment. 38(4). 408–411.
19.
Oviedo‐Joekes, Eugenia, Suzanne Brissette, David C. Marsh, et al.. (2009). Diacetylmorphine versus Methadone for the Treatment of Opioid Addiction. New England Journal of Medicine. 361(8). 777–786.
20.
Monga, Neerav, Jürgen Rehm, Benedikt Fischer, et al.. (2006). Using latent class analysis (LCA) to analyze patterns of drug use in a population of illegal opioid users. Drug and Alcohol Dependence. 88(1). 1–8.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Ambros Uchtenhagen Breakdown of academic impact, for papers by Uwe Verthein Breakdown of academic impact, for papers by Nick Lintzeris Breakdown of academic impact, for papers by John A. Renner Breakdown of academic impact, for papers by Genie L. Bailey Breakdown of academic impact, for papers by Helge Waal Breakdown of academic impact, for papers by Eugenia Oviedo‐Joekes Breakdown of academic impact, for papers by Kenneth B. Stoller Breakdown of academic impact, for papers by Christian Haasen Breakdown of academic impact, for papers by Lucy Thi Tran